SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-007996
Filing Date
2020-04-20
Accepted
2020-04-20 07:04:52
Documents
6
Period of Report
2020-04-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20200417_8k.htm 8-K 29827
2 EXHIBIT 4.1 ex_181776.htm EX-4.1 103674
3 EXHIBIT 10.1 ex_181774.htm EX-10.1 117622
4 EXHIBIT 10.2 ex_181775.htm EX-10.2 76996
5 EXHIBIT 99.1 ex_181860.htm EX-99.1 12770
6 img.jpg GRAPHIC 6329
  Complete submission text file 0001437749-20-007996.txt   350924
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 20801239
SIC: 2834 Pharmaceutical Preparations